Kamunting Street Capital Management, L.P. Bristol Myers Squibb CO Call Options Transaction History

Kamunting Street Capital Management, L.P.

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $3.85 Million - $4.56 Million	-90,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $4.02 Million - $4.44 Million	90,000 New	90,000 $4.08 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Kamunting Street Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Kamunting Street Capital Management, L.P. with notifications on news.